Asymptomatic liver injury due to erythromycin stearate

J. Alcalay, S. Halevy, E. Theodor, M. Sandbank

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


A 73-year-old woman with rosacea, who had started treatment with erythromycin stearate 2 g/d, developed asymptomatic liver injury. The drug was discontinued and the laboratory findings of liver damage disappeared within 11 days. This is the first report of erythromycin stearate-induced asymptomatic hepatotoxicity.

Original languageEnglish
Pages (from-to)601-602
Number of pages2
JournalDrug Intelligence and Clinical Pharmacy
Issue number7-8
StatePublished - 1986
Externally publishedYes


Dive into the research topics of 'Asymptomatic liver injury due to erythromycin stearate'. Together they form a unique fingerprint.

Cite this